IRD·67577R102·US·equity·Healthcare - Biotechnology-Activist
IRD (OPUS GENETICS INC) is held by 41 institutional investors as of Q1 2026. Largest holders: ADAGE CAPITAL PARTNERS GP, L.L.C. ($27.4M), BALYASNY ASSET MANAGEMENT L.P. ($12.4M), MILLENNIUM MANAGEMENT LLC ($12M). Net institutional sentiment: Mixed.
See how IRD's score breaks down across 4 SEC sources
Showing 1-20 of 45
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer